Palantir (PLTR) stock rises premarket ahead of Q2 earnings while facing new NHS contract scrutiny over its data platform.

Palantir stock has dropped substantially this year, with several valuation metrics showing that it is highly undervalued as earnings loom.

Palantir (PLTR) expected to report Q2 earnings of 35 cents per share and $1.81 billion in revenue. Analysts have mixed opinions on stock.